Cargando…
An acceptor analogue of β-1,4-galactosyltransferase: Substrate, inhibitor, or both?
Many glycosyltransferase inhibitors in the literature are structurally derived from the donor or acceptor substrate of the respective enzyme. A representative example is 2-naphthyl β-d-GlcNAc, a synthetic GlcNAc glycoside that has been reported as a galactosyltransferase inhibitor. This GlcNAc deriv...
Autores principales: | Jiang, Jingqian, Wagner, Gerd K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5636615/ https://www.ncbi.nlm.nih.gov/pubmed/28910600 http://dx.doi.org/10.1016/j.carres.2017.08.012 |
Ejemplares similares
-
Probing the Acceptor Active Site Organization of the Human Recombinant β1,4-Galactosyltransferase 7 and Design of Xyloside-based Inhibitors
por: Saliba, Mineem, et al.
Publicado: (2015) -
The Impact of β-1,4-Galactosyltransferase V on Microglial Function
por: Wang, Xiaoyu, et al.
Publicado: (2021) -
The impact of aminopyrene trisulfonate (APTS) label in acceptor glycan substrates for profiling plant pectin β-galactosyltransferase activities
por: Goetz, Stephan, et al.
Publicado: (2016) -
Glycosphingolipid-associated β-1,4 galactosyltransferase is elevated in patients with systemic lupus erythematosus
por: Sadras, Vignesh, et al.
Publicado: (2020) -
N-glycosylation of the human β1,4-galactosyltransferase 4 is crucial for its activity and Golgi localization
por: Shauchuk, Auhen, et al.
Publicado: (2020)